POS0592 Increased overall & cause-specific mortality in population-based cohort of people with incident #RA Higher mortality in RA vs gen pop but this has decreased after 2000 & better 10-year survival Severe causes of mortality incl cardiac higher in RA EULAR2024 @RheumNow

POS1035 FVC & risk of lung transplant & mortality in #RAILD 50% pts had FVC % predicted decline in ~6.5yrs 2/3 identified groups more strongly assoc w transplant or ILD-related death than INBUILD definition ➡️marked heterogeneity in ILD progression #EULAR2024 @RheumNow

📄 You can now read my article on #CardiovascularDisease, #Stroke & #Mortality @RheumNow! 🌟 Featuring 2 cohort studies from @MayoClinic, presented at #EULAR2024 🔗 https://t.co/b639vE5hSA @MyasoedovaElena

• Matters of the heart: cardiovascular disease and mortality in RA | RheumNow

#EULAR2024 OP0193 Watch out, blinatumomab will BiTE! Bi-specific T-cell engagers (BiTEs), kill Bcells by engaging Tcells. In 6 refractory #RA patients (failed 3 x ts/bDMARDs), deep blood & tissue depletion were met, good response. Brief raised temp but no cytokine storm @RheumNow https://t.co/OmxSbTXfZq

• https://twitter.com/Yuz6Yusof/status/1801644379829879176/photo/1
• https://twitter.com/Yuz6Yusof/status/1801644379829879176/photo/1

Fascinating - @ndb_org installed an app to measure smartphone usage, and texting less and moving less were associated with more flares. The pseudo-wearable in our pockets?? #EULAR2024 POS0678 @RheumNow https://t.co/ZA0hd3Q10d

• https://twitter.com/drdavidliew/status/1801644214742298844/photo/1

Is muscle US useful in RA? 100+ pts 1yr followup BL muscle thickness correlated w/ grip strength improvement HAQ improv correlated w/ pennation angle vastus lateralis No diff between muscle morphology & DAS I'd say it's still easier to US joints! @RheumNow #EULAR2024 POS1033

RA patients on abatacept have an appalling immunogenic response to Shingrix. Humoral fades away in the first year, and an absence of cellular responses. Alarming and need strategies to combat this #EULAR2024 POS0620 Winthrop/@RADoctor @RheumNow https://t.co/8gY9ocLBDp

• https://twitter.com/drdavidliew/status/1801641070629109908/photo/1

#EULAR2024 POS0390 What impact of regulatory warning on JAK-i on access to therapy? Data from UK BSSR-BR reported 4 in 5 #RA patients would have been considered ‘high-risk’. Of these, 28% had failed ≥3 biologics; so no suitable alternatives. Enormously impacted @RheumNow https://t.co/XeS9qHXSpH

• https://twitter.com/Yuz6Yusof/status/1801634766610964984/photo/1

What psychosocial factors drive treatment outcomes and disease activity for people living with rheumatoid arthritis? #EULAR2024 POS0309-PARE @DrMiniDey @ElenaNikiUK @RheumNow https://t.co/q0tTLSL044

• https://twitter.com/drdavidliew/status/1801634187000299677/photo/1